Ventilator-associated pneumonia in critically ill patients with subarachnoid haemorrhage: single-centre experience

被引:0
|
作者
Pluta, Michal P. [1 ,2 ]
Zachura, Mateusz N. [1 ,4 ]
Maslanka, Sebastian [3 ]
Sztuba, Karolina [3 ]
Mika, Jolanta [3 ]
Marczyk, Katarzyna [3 ]
Krzych, Lukasz J. [1 ,2 ]
机构
[1] Med Univ Silesia, Fac Med Sci Zabrze, Dept Acute Med, Katowice, Poland
[2] Silesian Ctr Hearth Dis, Dept Cardiac Anaesthes & Intens Therapy, Zabrze, Poland
[3] Med Univ Silesia, Fac Med Sci Zabrze, Dept Acute Med, Students Sci Soc, Katowice, Poland
[4] Med Univ Silesia, Fac Med Sci Zabrze, Dept Acute Med, Zabrze, Poland
关键词
embolisation; intracranial aneurysm; subarachnoid haemorrhage; ventilator-associated pneumonia; BRONCHOALVEOLAR LAVAGE FLUID; RISK-FACTORS; HEAD TRAUMA;
D O I
10.5114/ms.2023.134084
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: The need for prolonged mechanical ventilation (MV) in patients with subarachnoid haemorrhage (SAH) increases the risk of developing ventilation-associated pneumonia (VAP). Aim of the research: To assess the prevalence of VAP and to determine its aetiological factors.Material and methods: The study group consisted of 58 critically ill patients treated between 01.2019 and 10.2021. Demographic and clinical data were collected, including the method of collecting material from the respiratory tract, and results of laboratory and microbiological tests.Results: More than 97% of patients were intubated on the day of admission to the ICU. The median duration of MV was 8 days (IQR: 3-19). On admission, 47 microbiological samples from the respiratory tract (39 endotracheal aspirates, 8 bronchopulmonary lavage) were collected, 26 of which (55%) were physiological flora. In the following days, VAP was diagnosed in 9/47 patients (19%). The median time from admission to diagnosis was 3.5 days (IQR: 3-4.5). Multi-drug-resistant species were found in 3 patients (K. pneumoniae ESBL+). In-hospital mortality among patients with VAP was 62%. None of the patients with SAH and VAP was liberated from ventilator.Conclusions: In patients with SAH, early-onset VAP is frequent, and its aetiology is unrelated with bacterial colonization found on ICU admission. Even in EO-VAP, multidrug-resistant (MDR) bacteria must be suspected, mostly causing hospital acquired pneumonia. Prognosis of patients with SAH who develop VAP is poor.
引用
收藏
页码:334 / 341
页数:8
相关论文
共 50 条
  • [31] Population pharmacokinetics of single-dose amikacin in critically ill patients with suspected ventilator-associated pneumonia
    Burdet, C.
    Pajot, O.
    Couffignal, C.
    Armand-Lefevre, L.
    Foucrier, A.
    Laouenan, C.
    Wolff, M.
    Massias, L.
    Mentre, F.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 71 (01) : 75 - 83
  • [32] Population pharmacokinetics of single-dose amikacin in critically ill patients with suspected ventilator-associated pneumonia
    C. Burdet
    O. Pajot
    C. Couffignal
    L. Armand-Lefèvre
    A. Foucrier
    C. Laouénan
    M. Wolff
    L. Massias
    F. Mentré
    European Journal of Clinical Pharmacology, 2015, 71 : 75 - 83
  • [33] Penetration of gentamicin into the alveolar lining fluid of critically ill patients with ventilator-associated pneumonia
    Panidis, D
    Markantonis, SL
    Boutzouka, M
    Karatzas, S
    Baltopoulos, G
    CHEST, 2005, 128 (02) : 545 - 552
  • [34] Effect of heat and moisture exchangers on the prevention of ventilator-associated pneumonia in critically ill patients
    Auxiliadora-Martins, M.
    Menegueti, M. G.
    Nicolini, E. A.
    Alkmim-Teixeira, G. C.
    Bellissimo-Rodrigues, F.
    Martins-Filho, O. A.
    Basile-Filho, A.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2012, 45 (12) : 1295 - 1300
  • [35] Lung ultrasound: a promising tool to monitor ventilator-associated pneumonia in critically ill patients
    Wang, Guyi
    Ji, Xiaoying
    Xu, Yongshan
    Xiang, Xudong
    CRITICAL CARE, 2016, 20
  • [36] The chest radiograph in critically ill surgical patients is inaccurate in predicting ventilator-associated pneumonia
    Butler, KL
    Sinclair, KE
    Henderson, VJ
    McKinney, G
    Mesidor, DA
    Katon-Benitez, I
    Weaver, WL
    AMERICAN SURGEON, 1999, 65 (09) : 805 - 809
  • [37] Proteomic Profiling of Bronchoalveolar Lavage Fluid in Critically Ill Patients with Ventilator-Associated Pneumonia
    Nguyen, Elizabeth V.
    Gharib, Sina A.
    Palazzo, Steven J.
    Chow, Yu-hua
    Goodlett, David R.
    Schnapp, Lynn M.
    PLOS ONE, 2013, 8 (03):
  • [38] Obesity and the Incidence of Ventilator-Associated Pneumonia in Critically Ill Patients With Shock The Paradox Persists
    Aretha, Diamanto
    Kiekkas, Panagiotis
    CHEST, 2021, 159 (06) : 2135 - 2136
  • [39] Pharmacokinetics and intrapulmonary concentrations of linezolid administered to critically ill patients with ventilator-associated pneumonia
    Boselli, E
    Breilh, D
    Rimmelé, T
    Djabarouti, S
    Toutain, A
    Chassard, D
    Saux, MC
    Allaouchiche, B
    CRITICAL CARE MEDICINE, 2005, 33 (07) : 1529 - 1533
  • [40] Clinical and epidemiological risk factors for ventilator-associated pneumonia in a cohort of critically ill patients
    G De Pascale
    MA Pennisi
    V Raggi
    E Piervincenzi
    V Bernini
    A Occhionero
    P De Santis
    A Moccaldo
    S Cicconi
    R Maviglia
    M Tumbarello
    M Antonelli
    Critical Care, 16 (Suppl 1):